FDA Clearance Tracker · P980040-S065
TECNIS SYMFONY EXTENDED RANGE OF VISION INTRAOCULAR LENS
Last checked: Nov 20, 2026Latest source record: Jul 15, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jul 15, 2016
Approved
Time to decision
178 days
Received Jan 19, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P980040-S065
- Device name
- TECNIS SYMFONY EXTENDED RANGE OF VISION INTRAOCULAR LENS
- Applicant location
- Irvine, CA
- Received
- Jan 19, 2016
- Decided
- Jul 15, 2016
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P980040
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the Tecnis Symfony Extended Range of Vision Intraocular Lens. The TECNIS® Symfony Extended Range of Vision IOL, Model ZXR00, is indicated for primary implantation for the visual correction of aphakia, in adult patients with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the lens provides improved intermediate and near visual acuity, while maintaining comparable distance visual acuity. The Model ZXR00 IOL is intended for capsular bag placement only. The TECNIS® Symfony Toric Extended Range of Vision IOLs, Models ZXT150, ZXT225, ZXT300, and ZXT375, are indicated for primary implantation for the visual correction of aphakia and for reduction of residual refractive astigmatism in adult patients with greater than or equal to 1 diopter of preoperative corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the lens provides improved intermediate and near visual acuity, while maintaining comparable distance visual acuity. The Model Series ZXT IOLs are intended for capsular bag placement only.
Source documents
Other decisions for Johnson & Johnson Surgical Vision, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TECNIS PureSee IOL, Model DEN00V TECNIS PureSee Toric II IOLs, Model DET150, DET225, DET300, DET375PMA supplement
P980040-S176 · Decided Mar 11, 2026 · 223 days after receipt · Panel Track
Device type: intraocular lens (HQL) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.